Transcripts

Relmada Therapeutics (RLMD) earnings call transcripts

Earnings call transcripts for Relmada Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as an execution phase, with manufacturing the remaining gate to IND filing and registration-enabling trials.

    Aug 06, 2026Positive0.48